Previous close | 0.4200 |
Open | 0.3700 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.3700 - 0.3700 |
52-week range | 0.3700 - 0.4200 |
Volume | |
Avg. volume | 174 |
Market cap | 27.275M |
Beta (5Y monthly) | 1.38 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
PARIS, May 17, 2024--Regulatory News: Mauna Kea Technologies (Paris:ALMKT):
PARIS & BOSTON, May 06, 2024--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announced the presentation of 9 abstracts supporting Cellvizio® at the Digestive Disease Week® (DDW) Conference, being held on May 18-21, 2024 in Washington, DC. These abstracts focus on artificial intelligence, pancreatic cystic lesions and pancreatic cancer, food intolerance an
PARIS & BOSTON, April 30, 2024--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT) (Paris:ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announced that it has published its Annual Financial Report for the year ended 31 December 2023 and filed it with the Autorité des Marchés Financiers (AMF) on 30 April 2024.